DEAR DR. ROACH: Since starting blood thinners, I’m unable to continue anti-inflammatories for ongoing arthritis pain. Is there a safe arthritis pain medication ... or two extra-strength pills ...

Introduction: Patellofemoral Pain Syndrome ... use of medication; previous physical therapy; and inability to perform the functional tests proposed in this study or to attend the scheduled assessments ...

One of those things is an increase in pain tolerance. Swearing is “a drug-free, calorie-neutral ... been shown to be linked with an increase in strength. Looking at the impact of swearing ...

Sarah Richards never imagined she’d end up struggling with pain medication. After a car accident left her with chronic back pain, prescription opioids seemed like a lifeline. Three months later ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been ...

A new type of pain medication to hit the market will create an alternative —it’s not an opioid — and could open the door to more drugs of this type in the future. CNN values your feedback 1.

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years. “Today’s approval is an important public health ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions. The Food and Drug Administration on Thursday ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx ...